HeartFlow, a company that specializes in creating computerized heart models to treat coronary diseases, announced that its HeartFlow fractional flow reserved from CT (FFRct) Analysis will be covered ...

A chemotherapy drug used to fight bone-marrow cancer also has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.

The first anatomical and personal heart model that could save the lives of children with life-threatening heart abnormalities was made in a partnership between a local physician and an ASU biomedical ...